Last reviewed · How we verify
Evaluation of Hypnosis in Virtual Reality on the Anxiety of Patients With Metastatic Prostate Cancer Over Chemotherapy (HypProMet)
Prostate cancer is the first cancer in men. The treatment of metastatic prostate cancer with chemotherapy is based on the intravenous administration of docetaxel chemotherapy. Symptoms of anticipatory nausea, linked to anxiety caused by the treatment, may occur. Hypnosis is already used to treat the anxiety of people with cancer and can help treat the symtoms of nausea and vomiting of women with breast cancer. The purpose of the study is to evaluate the effect of medical hypnosis in virtual reality on the anxiety of patients with metastatic prostate cancer receiving Docetaxel chemotherapy treatment in comparison with a control group.
Details
| Lead sponsor | Saint-Gregoire Private Hospital Center |
|---|---|
| Phase | NA |
| Status | COMPLETED |
| Enrolment | 53 |
| Start date | Mon Sep 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Sat Feb 28 2026 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Metastatic Prostate Cancer
Interventions
- HYPNO VR® device
Countries
Portugal, France